Related Experiment Video
Updated: Sep 2, 2026

Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
E3 Ubiquitin Ligase MDM2 Contributes to Proliferation, Migration/Invasion, Epithelial-Mesenchymal Transition, and
Yanfeng Fang1, Wenting Wu1, Miaomiao Wen2
1Department of Respiratory and Critical Care Medicine, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.
Abstract:
Lung cancer remains the leading cause of cancer-associated death, and aerobic glycolysis is a key hallmark of cancer. Ubiquitination is a post-translational modification involved in the regulation of lung cancer progression. The aim of this study was to investigate E3 ubiquitin ligase mouse double minute 2 (MDM2) and its ubiquitination on myosin heavy chain 11 (MYH11) in lung cancer progression and glycolytic reprogramming. Expression of MYH11 was analyzed using online databases. MDM2 and MYH11 mRNA and protein detection was performed by qPCR and Western blot. Cell proliferation, migration, and invasion were respectively detected using colony formation assay, wound healing assay, and transwell assay. Glycolysis was evaluated by measuring lactate production and glucose consumption. Epithelial-mesenchymal transition (EMT) and glycolysis-associated proteins were measured using Western blot. Xenograft tumor model was established for in vivo analysis. Co-immunoprecipitation (Co-IP) assay was performed to assess ubiquitination effect of MDM2 on MYH11 and their protein interaction. MYH11 was a down-regulated gene in lung cancer and it negatively correlated with glycolysis. Lung cancer cell proliferation, migration, invasion, EMT, and glycolysis were significantly inhibited following MYH11 overexpression. Tumor growth in vivo was also reduced by MYH11. Mechanistically, MDM2 mediated ubiquitination of MYH11 to induce MYH11 protein degradation and downregulation. Knockdown of MDM2 suppressed the malignant phenotypes of lung cancer cells via enhancing MYH11 protein stability in vitro and in vivo. These results suggest that MDM2 reduces MYH11 expression via ubiquitination-mediated degradation of MYH11 protein, thereby enhancing lung cancer cell proliferation, migration/invasion, EMT and glycolysis, and ultimately promoting tumor progression.
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitogens and the Cell Cycle
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Master Transcription Regulators
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...